Header Logo

Connection

Christopher Seder to Lung Neoplasms

Back to Details
This is a "connection" page, showing publications Christopher Seder has written about Lung Neoplasms.
Christopher Seder
Connection Strength
9.243
Lung Neoplasms
  1. Robotic vs Thoracoscopic Anatomic Lung Resection in Obese Patients: A Propensity-Adjusted Analysis. Ann Thorac Surg. 2022 11; 114(5):1879-1885.
    View in: PubMed
    Score: 0.533
  2. Redefining the Risk of Surgery for Clinical Stage IIIA (N2) Non-Small Cell Lung Cancer: A Pooled Analysis of the STS GTSD and ESTS Registry. Lung. 2021 06; 199(3):311-318.
    View in: PubMed
    Score: 0.514
  3. Reply to "Letter to the editor of Annals of Surgical Oncology Concerning " The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer" by Sunil Kumar et al. Ann Surg Oncol. 2021 06; 28(6):3433-3434.
    View in: PubMed
    Score: 0.496
  4. The Landmark Series: Multimodality Therapy for Stage 3A Non-small Cell Lung Cancer. Ann Surg Oncol. 2020 Aug; 27(8):3030-3036.
    View in: PubMed
    Score: 0.480
  5. Commentary: Has the Time Finally Arrived for Radiofrequency Ablation to Enter the Game? Semin Thorac Cardiovasc Surg. 2020; 32(3):580-581.
    View in: PubMed
    Score: 0.474
  6. A Prolonged Air Leak Score for Lung Cancer Resection: An Analysis of The Society of Thoracic Surgeons General Thoracic Surgery Database. Ann Thorac Surg. 2019 11; 108(5):1478-1483.
    View in: PubMed
    Score: 0.454
  7. Reply. Ann Thorac Surg. 2018 07; 106(1):316-317.
    View in: PubMed
    Score: 0.408
  8. Serum Biomarkers May Prognosticate Recurrence in Node-Negative, Non-Small Cell Lung Cancers Less Than 4 Centimeters. Ann Thorac Surg. 2017 Nov; 104(5):1637-1643.
    View in: PubMed
    Score: 0.401
  9. Lung cancer screening is here to stay, but does it pay? J Thorac Cardiovasc Surg. 2018 01; 155(1):426-427.
    View in: PubMed
    Score: 0.400
  10. The Society of Thoracic Surgeons General Thoracic Surgery Database 2017 Update on Outcomes and Quality. Ann Thorac Surg. 2017 May; 103(5):1378-1383.
    View in: PubMed
    Score: 0.390
  11. Number of Ribs Resected is Associated with Respiratory Complications Following Lobectomy with en bloc Chest Wall Resection. Lung. 2016 08; 194(4):619-24.
    View in: PubMed
    Score: 0.363
  12. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer. J Thorac Cardiovasc Surg. 2016 Jul; 152(1):55-61.e1.
    View in: PubMed
    Score: 0.362
  13. The Society of Thoracic Surgeons General Thoracic Surgery Database Update on Outcomes and Quality. Ann Thorac Surg. 2016 May; 101(5):1646-54.
    View in: PubMed
    Score: 0.361
  14. Variation in Pulmonary Resection Practices Between The Society of Thoracic Surgeons and the European Society of Thoracic Surgeons General Thoracic Surgery Databases. Ann Thorac Surg. 2016 Jun; 101(6):2077-84.
    View in: PubMed
    Score: 0.361
  15. Four Synchronous Primary Malignancies of the Breast, Lung, Colon and Esophagus. Anticancer Res. 2015 Nov; 35(11):6159-62.
    View in: PubMed
    Score: 0.351
  16. Unresectable Middle Mediastinal Biphasic Pulmonary Blastoma. Anticancer Res. 2015 Nov; 35(11):6325-7.
    View in: PubMed
    Score: 0.351
  17. Angiogenesis Biomarkers May Be Useful in the Management of Patients With Indeterminate Pulmonary Nodules. Ann Thorac Surg. 2015 Aug; 100(2):429-36.
    View in: PubMed
    Score: 0.343
  18. Stage IIIA non-small cell lung cancer: morbidity and mortality of three distinct multimodality regimens. Ann Thorac Surg. 2013 May; 95(5):1708-16.
    View in: PubMed
    Score: 0.293
  19. The safe transition from open to thoracoscopic lobectomy: a 5-year experience. Ann Thorac Surg. 2009 Jul; 88(1):216-25; discussion 225-6.
    View in: PubMed
    Score: 0.226
  20. Upregulated INHBA expression may promote cell proliferation and is associated with poor survival in lung adenocarcinoma. Neoplasia. 2009 Apr; 11(4):388-96.
    View in: PubMed
    Score: 0.222
  21. The role of IGF-pathway biomarkers in determining risks, screening, and prognosis in lung cancer. Oncotarget. 2022; 13:393-407.
    View in: PubMed
    Score: 0.136
  22. Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung. Interact Cardiovasc Thorac Surg. 2021 11 22; 33(6):879-884.
    View in: PubMed
    Score: 0.134
  23. Consensus for Thoracoscopic Lower Lobectomy: Essential Components and Targets for Simulation. Ann Thorac Surg. 2022 11; 114(5):1895-1901.
    View in: PubMed
    Score: 0.133
  24. The Society of Thoracic Surgeons Composite Score Rating for Pulmonary Resection for Lung Cancer. Ann Thorac Surg. 2020 03; 109(3):848-855.
    View in: PubMed
    Score: 0.116
  25. Improved False-Positive Rates and the Overestimation of Unintended Harm from Lung Cancer Screening. Lung. 2019 06; 197(3):327-332.
    View in: PubMed
    Score: 0.111
  26. Defining Proficiency for The Society of Thoracic Surgeons Participants Performing Thoracoscopic Lobectomy. Ann Thorac Surg. 2019 01; 107(1):202-208.
    View in: PubMed
    Score: 0.107
  27. Circulating histocompatibility antigen (HLA) gene products may help differentiate benign from malignant indeterminate pulmonary lesions. Hum Immunol. 2018 Jul; 79(7):558-563.
    View in: PubMed
    Score: 0.104
  28. Development of bead based multiplexed immunoassay for evaluation of midkine, syndecan-1, and ANGPTL4 in patient serum. J Immunoassay Immunochem. 2018; 39(1):84-98.
    View in: PubMed
    Score: 0.103
  29. Video-Assisted Thoracoscopic Lobectomy for Lung Cancer: Current Practice Patterns and Predictors of Adoption. Ann Thorac Surg. 2016 Dec; 102(6):1854-1862.
    View in: PubMed
    Score: 0.093
  30. The Society of Thoracic Surgeons Lung Cancer Resection Risk Model: Higher Quality Data and Superior Outcomes. Ann Thorac Surg. 2016 Aug; 102(2):370-7.
    View in: PubMed
    Score: 0.091
  31. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):307-16.
    View in: PubMed
    Score: 0.084
  32. Circulating angiogenesis biomarkers are associated with disease progression in lung adenocarcinoma. Ann Thorac Surg. 2014 Dec; 98(6):1968-75; discussion 1975.
    View in: PubMed
    Score: 0.082
  33. Value of circulating insulin-like growth factor-associated proteins for the detection of stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2015 Mar; 149(3):727-34.e1-3; discussion 734.
    View in: PubMed
    Score: 0.081
  34. AZGP1 autoantibody predicts survival and histone deacetylase inhibitors increase expression in lung adenocarcinoma. J Thorac Oncol. 2008 Nov; 3(11):1236-44.
    View in: PubMed
    Score: 0.054
  35. Consensus for Thoracoscopic Left Upper Lobectomy-Essential Components and Targets for Simulation. Ann Thorac Surg. 2021 08; 112(2):436-442.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.